Clinical Trial Update: Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating early methicillin-resistant Staphylococcus aureus therapy in cystic fibrosis was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Methicillin-resistant Staphylococcus Aureus

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus | Phase 2 | Status: TERMINATED | Results posted: 2017-05-15